Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Alan F. Joslyn"'
Publikováno v:
Neurogastroenterology & Motility. 3:46-52
Changes in cyclic nucleotide content arc associated with relaxation of lower esophageal sphincter (LES) smooth muscle. Although agents that increase cyclic AMP (cAMP) or cyclic CMP (cGMP) can relax the LES, relaxation produced by activation of enteri
Autor:
Michael H. Pearman, Fred M. Cox, Samia N. Khalil, Anthony L. Kovac, Barbara A. Prillaman, Alan F. Joslyn, Phillip E. Scuderi
Publikováno v:
Journal of Clinical Anesthesia. 8:644-651
Study Objectives: To determine (1) the efficacy and safety of ondansetron in the prevention of postoperative nausea and vomiting (PONV) in male outpatients; (2) prognostic factors for PONV in male outpatients; and (3) patients' perceptions of the deb
Autor:
Julius R. Bowie, Alan F. Joslyn, Jennifer Lessin, Boonrak Tantisira, Rafael Miguel, Mark Dershwitz, John B. Downs, Carl E. Rosow, Fred Rosenblum, Patricia M. DiBiase, Ray McKenzie, Stephen Odell, Kevin Sheahan, Mary Nations, Said Sharifi-Azad
Publikováno v:
Journal of Clinical Anesthesia. 5:30-36
To compare the efficacy and safety profiles of intravenous (IV) ondansetron (two 8 mg doses 8 hours apart) and a placebo when used in the prevention of postoperative nausea and emesis (vomiting or retching).Randomized, double-blind, placebo-controlle
Publikováno v:
Clinical Pharmacology and Therapeutics. 52:96-101
The efficacy of ondansetron, a selective 5-HT3 receptor antagonist, in preventing postoperative nausea and vomiting in surgical patients was studied. Fifty women were randomized in a double-blind manner to receive either two 8 mg doses of intravenous
Publikováno v:
Journal of clinical anesthesia. 5(1)
Study Objective : To compare the efficacy and safety profiles of ondansetron and a placebo when infused immediately prior to anesthesia induction for the prevention of postoperative nausea and emesis (vomiting or retching). Design : Randomized, doubl
Autor:
Mark Dershwitz, Carl E. Rosow, Roger S. Wilson, Patricia M. Di Biase, Polly E. Sanderson, Alan F. Joslyn
Publikováno v:
Anesthesiology. 77(3)
Ondansetron is a selective 5-hydroxytryptamine type 3 receptor antagonist effective as an antiemetic in patients experiencing post-operative or cancer chemotherapy-induced nausea and vomiting. Currently, no information is available regarding the inte
Publikováno v:
Anesthesiology. 73
Publikováno v:
Anesthesiology. 73